Copyright
©The Author(s) 2021.
World J Gastroenterol. Jul 28, 2021; 27(28): 4504-4535
Published online Jul 28, 2021. doi: 10.3748/wjg.v27.i28.4504
Published online Jul 28, 2021. doi: 10.3748/wjg.v27.i28.4504
Table 3 Incidence of hepatic abnormalities in patients with severe acute respiratory syndrome coronavirus 2 infection
| Ref. | Patient number | ALT (U/L) | AST (U/L) | TB (mg/dL) |
| Zhou et al[32], 2020 | 191 | ↑59 (31%) | None | NA |
| Shu et al[227], 2021 | 545 | ↑41 (7.5%) | ↑35 (10.1%) | ↑189 (34.7%) |
| Huang et al[25], 2020 | 41 | NA | ↑15 (37%) | NA |
| Huang et al[228], 2020 | 36 | 4 (13.3%) | 18 (58%) | ↑4 (12.9%) |
| Chen et al[26], 2020 | 99 | ↑28 (28%) | ↑35 (35%) | ↑18 (18%) |
| Ai et al[64], 2020 | 102 | ↑20 (19.6%) | ↑26 (25.5%) | NA |
| Xu et al[27], 2020 | 62 | ↑3 (3.75%) | ↑3 (3.75%) | NA |
| Yang et al[3], 2020 | 168 | ↑9 (8%) | ↑18 (17.3%) | ↑7 (6.4%) |
| Wu et al[28], 2020 | 80 | ↑3 (3.75%) | ↑3 (3.75%) | NA |
| Yao et al[229], 2020 | 40 | ↑21 (52.5%) | ↑16 (40%) | |
| Xu et al[230], 2020 | 355 | ↑91 (25.6%) | ↑102 (28.7%) | ↑10 (25%) |
| Cai et al[231], 2020 | 298 | ↑39 (13.1%) | ↑25 (8.4%) | ↑66 (18.6) |
| Richardson et al[1], 2020 | 5700 | ↑2176 (39.0%) | ↑3263 (58.4%) | ↑24 (8.1%) |
| NA | ||||
| Fan et al[1], 2020 | 40 | ↑27 (18.2%) | ↑32 (21.6%) | ↑9 (6.1%) |
| Guan et al[39], 2020 | 355 | ↑158 (21.3%) | ↑168 (22.2%) | ↑76 (10.5%) |
- Citation: Mohamed DZ, Ghoneim MES, Abu-Risha SES, Abdelsalam RA, Farag MA. Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management. World J Gastroenterol 2021; 27(28): 4504-4535
- URL: https://www.wjgnet.com/1007-9327/full/v27/i28/4504.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i28.4504